Boyalife Pharmaceuticals is engaged in the research and development of innovative therapies addressing a broad range of disease areas, including central nervous system, cardiovascular, cerebrovascular, autoimmune diseases, metabolic syndrome, diabetes and cancer. The Boyalife Pharmaceuticals team is comprised of highly-experienced researchers and scientists from some of the world’s foremost pharmaceutical and biotechnology companies, and maintains ongoing relationships with leading universities and research institutions throughout China.
